Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease
NCT01167543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79
Last updated 2010-07-22
Summary
This study investigates the prevalence and pathophysiology of dental and periodontal involvement in pediatric patients with symptomatic or asymptomatic gastroesophageal reflux (GER) or gastroesophageal reflux disease (GERD). Primary objectives are to compare the prevalence of oral disease in children with and without a diagnosis or symptoms/signs of GERD in a cross-sectional study. Secondary objectives are to examine factors that might lead to the pathogenesis of the dental and periodontal lesions observed in this group of subjects.
The primary hypothesis is to prove that children aged 10-18 years diagnosed with or having symptoms or signs of GERD have a significantly higher amount of dental erosions in comparison to a matched control group.
Secondary hypotheses are that children aged 10 - 18 years diagnosed with or having signs of GER have higher DMFS (Decayed, Missing, Filled permanent tooth Surfaces) rates, higher SBI (Sulcus Bleeding Index) rates, worse Periodontal status, and lower saliva buffering capacity.
Conditions
- Gastroesophageal Reflux
- Dental Erosion
Sponsors & Collaborators
-
Takeda Pharmaceuticals North America, Inc.
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Eligibility
- Min Age
- 9 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-09-30
- Completion
- 2008-11-30
Countries
- United States
Study Locations
More Related Trials
-
Natural History of Gastroesophageal Reflux (GER) in Children < 12 Years of Age
NCT01048840 ·Status: COMPLETED
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City
NCT06585176 ·Status: COMPLETED
-
Gastroesophageal Reflux Disease Among College Students
NCT04034017 ·Status: COMPLETED
-
The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department
NCT02506634 ·Status: COMPLETED
-
A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old
NCT02616302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00222170 ·Status: COMPLETED ·Phase: PHASE2
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
NCT00524355 ·Status: COMPLETED
-
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents
NCT01642602 ·Status: COMPLETED ·Phase: PHASE2
-
Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication
NCT02934152 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00911534 ·Status: COMPLETED ·Phase: PHASE3
-
GI Reflux in Lung Transplant and Its Relationship to Chronic Rejection
NCT00455078 ·Status: COMPLETED
-
Morphological Markers of Gastroesophageal Reflux Disease (GERD)
NCT01921686 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)
NCT00163306 ·Status: COMPLETED ·Phase: PHASE3
-
The Relationship Between Dietary Habit and Gastroesophageal Flap Valve Abnormality
NCT01194544 ·Status: UNKNOWN
-
Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only
NCT01536457 ·Status: COMPLETED
-
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
NCT00768443 ·Status: COMPLETED
-
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients
NCT00787891 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT06974903 ·Status: COMPLETED
-
Esomeprazole for Treatment of GERD in Pediatric Patients
NCT00228527 ·Status: COMPLETED ·Phase: PHASE4
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
What is the Predictive Value of the Reflux Impact Scale
NCT00536328 ·Status: TERMINATED
-
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
NCT00132496 ·Status: COMPLETED ·Phase: PHASE2
-
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
NCT02351960 ·Status: COMPLETED ·Phase: PHASE4